div class=trans-pagebuttonPage 1button div class=trans-image a href=https:reader030fdocumentsmxreader030viewer20220312005bb7b89f09d3f2a4338dc835html5page1jpg target=_blank amp-img class=trans-thumb alt=Page 1: · nar crónica esclerodermia e síndromes hereditários e congénitoslß Quadro 1 Cerca de 90% dos doentes com angio- displasia permanecem assintomáticos pelo que a observacão src=https:reader030fdocumentsmxreader030viewer20220312005bb7b89f09d3f2a4338dc835html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 2button div class=trans-image a href=https:reader030fdocumentsmxreader030viewer20220312005bb7b89f09d3f2a4338dc835html5page2jpg target=_blank amp-img class=trans-thumb alt=Page 2: · nar crónica esclerodermia e síndromes hereditários e congénitoslß Quadro 1 Cerca de 90% dos doentes com angio- displasia permanecem assintomáticos pelo que a observacão src=https:reader030fdocumentsmxreader030viewer20220312005bb7b89f09d3f2a4338dc835html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 3button div class=trans-image a href=https:reader030fdocumentsmxreader030viewer20220312005bb7b89f09d3f2a4338dc835html5page3jpg target=_blank amp-img class=trans-thumb alt=Page 3: · nar crónica esclerodermia e síndromes hereditários e congénitoslß Quadro 1 Cerca de 90% dos doentes com angio- displasia permanecem assintomáticos pelo que a observacão src=https:reader030fdocumentsmxreader030viewer20220312005bb7b89f09d3f2a4338dc835html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 4button div class=trans-image a href=https:reader030fdocumentsmxreader030viewer20220312005bb7b89f09d3f2a4338dc835html5page4jpg target=_blank amp-img class=trans-thumb alt=Page 4: · nar crónica esclerodermia e síndromes hereditários e congénitoslß Quadro 1 Cerca de 90% dos doentes com angio- displasia permanecem...